UnknownNot Applicable

Brain Imaging After Non-traumatic Intracranial Hemorrhage (SAVEBRAINPWI)

Belgium100 participantsStarted 2022-03-01

Plain-language summary

The study is an observational prospective evaluation of an approved and unchanged clinical management, evaluating different diagnosis methods to assess brain perfusion in patients with an aneurysmal or AVM-related intracranial hemorrhage

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age ≥ 18 years
✓. Non-traumatic intracranial hemorrhage (subarachnoid hemorrhage secondary to a ruptured aneurysm or AVM, unknown cause, per procedural bleed)
✓. In case of ruptured aneurysm, AVM or other etiology : need to be secured with surgical clipping or endovascular intervention if judged possible
✓. No contra-indication to perfusion imaging
✓. Subject or legal representative is able and willing to give informed consent.

Exclusion criteria

✕. Traumatic intracranial hemorrhage
✕. Contra-indication to imaging or patient's refusal.

What they're measuring

Change in brain hypoperfusion

Timeframe: Change between day 0, 5, 9 after Intracranial Hemorrhage

Trial details

NCT IDNCT05276934

SponsorErasme University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-10-20

Contact for this trial

Comite ethique hopital Erasme

003225553707 comite.ethique@erasme.ulb.ac.be

View on ClinicalTrials.gov More Aneurysm, Ruptured trials